People · Operator

Neil Graham

Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology

1
Companies
2
Filings
$128.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Zura Bio LtdBiotechnologySeries D+$128.4M$1.3B2023
Operator network

Neil Graham at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Amit Munshi · 5 companies · 1 sharedAmit MunshiMichael Howell · 3 companies · 1 sharedMichael HowellKim Davis · 2 companies · 1 sharedKim DavisSandeep Kulkarni · 2 companies · 1 sharedSandeep KulkarniSteven Schoch · 2 companies · 1 sharedSteven SchochArnout Ploos Van Amstel · 1 companies · 1 sharedArnout Ploos Van …Christopher Cabell · 1 companies · 1 sharedChristopher CabellGarry Neil · 1 companies · 1 sharedGarry NeilGary Whale · 1 companies · 1 sharedGary WhaleJennifer Jarrett · 1 companies · 1 sharedJennifer JarrettKiran Nistala · 1 companies · 1 sharedKiran NistalaParvinder Thiara · 1 companies · 1 sharedParvinder ThiaraRobert Lisicki · 1 companies · 1 sharedRobert LisickiSomeit Sidhu · 1 companies · 1 sharedSomeit SidhuVerender Badial · 1 companies · 1 sharedVerender BadialZura Bio Ltd · $128.4M raisedZura Bio LtdNeil GrahamNG
Neil Graham Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Neil Graham on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Amit Munshi15
Michael Howell13
Steven Schoch12
Sandeep Kulkarni12
Kim Davis12
Gary Whale11
Verender Badial11
Robert Lisicki11
Jennifer Jarrett11
Someit Sidhu11
Christopher Cabell11
Arnout Ploos Van Amstel11
Parvinder Thiara11
Garry Neil11
Kiran Nistala11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.